Ascletis Pharma Inc.
ASCLF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,580 | $866 | $343 | $330 |
| Short-Term Investments | $200 | $1,082 | $1,737 | $1,969 |
| Receivables | $0 | $5 | $13 | $5 |
| Inventory | $5 | $4 | $6 | $6 |
| Other Curr. Assets | $17 | $14 | $16 | $22 |
| Total Curr. Assets | $1,823 | $1,971 | $2,115 | $2,333 |
| Property Plant & Equip (Net) | $52 | $57 | $65 | $69 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $11 | $12 | $24 | $26 |
| Long-Term Investments | $111 | -$997 | $71 | $63 |
| Tax Assets | $0 | $0 | $0 | -$0 |
| Other NC Assets | $0 | $1,082 | $0 | $1 |
| Total NC Assets | $174 | $154 | $161 | $158 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,997 | $2,125 | $2,276 | $2,491 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $1 |
| Short-Term Debt | $4 | $6 | $5 | $6 |
| Tax Payable | $0 | $4 | $0 | $2 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $122 | $143 | $82 | $133 |
| Total Curr. Liab. | $125 | $153 | $87 | $141 |
| LT Debt | $1 | $1 | $4 | $3 |
| Deferred Rev, NC | $0 | $4 | $0 | $6 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | -$6 |
| Other NC Liab. | $3 | $0 | $5 | $6 |
| Total NC Liab. | $4 | $5 | $9 | $8 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $8 | $9 | $8 |
| Total Liabilities | $129 | $158 | $96 | $149 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $1,174 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | $0 | -$1,475 | $0 | -$1,174 |
| AOCI | $1,867 | $748 | $2,180 | $0 |
| Other Equity | $0 | $2,693 | $0 | $2,791 |
| Total Equity | $1,868 | $1,966 | $2,180 | $2,342 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,997 | $2,125 | $2,276 | $2,491 |
| Net Debt | -$1,576 | -$858 | -$334 | -$322 |